cancer screening
Leveraging resources such as virtual data rooms and shared labs makes it easier for biotech startups to grow. This is good news: We need more companies attacking cancer from novel…
AI
C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B
7:00 am PDT • April 15, 2021
If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will…
Startups
Lucence raises $20 million Series A for its non-invasive cancer screening technology
3:00 pm PST • November 19, 2019
Lucence Diagnostics, a genomic medicine startup that develops non-invasive tests for cancer screening, announced today that it has raised a $20 million Series A led by IHH Healthcare, one of…
